<?xml version="1.0" encoding="UTF-8"?>
<p>The above results indicate that 
 <bold>TPBIA </bold>might have therapeutic potential in the treatment of psychosis, due to its dopamine antagonistic activity in the central nervous system. In addition, its antioxidant effects is a desirable property, since tardive dyskinesia – a neuroleptics' severe side effect – has been attributed, at least in part, to oxidative stress.
</p>
